Paul Hartmann AG

FRA-PHH2
Frankfurt Stock Exchange
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Global Rank
#9482
Country Rank
#163
Market Cap
1.01 B
Price
280.65
Change (%)
3.61%
Volume
45

Paul Hartmann AG's latest marketcap:

1.01 B

As of 06/27/2025, Paul Hartmann AG's market capitalization has reached $1.01 B. According to our data, Paul Hartmann AG is the 9482th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.01 B
Revenue (ttm) 2.84 B
Net Income (ttm) 126.82 M
Shares Out 3.55 M
EPS (ttm) 35.71
Forward PE 0.00
Ex-Dividend Date 05/02/2025
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 06/27/2025

Paul Hartmann AG's yearly market capitalization.

Paul Hartmann AG has seen its market value drop from €1.13 B to €1.01 B since 2014, representing a total decrease of 10.95% and an annual compound decline rate (CAGR) of 1.10%.
Date Market Cap Change (%) Global Rank
06/27/2025 €1.01 B 10.91% 9482
12/30/2024 €781.38 M 6.8% 9951
12/29/2023 €731.66 M -0.96% 9911
12/30/2022 €738.76 M -38.28% 9534
12/30/2021 €1.2 B -5.34% 7752
12/30/2020 €1.26 B 26.24% 6210
12/30/2019 €1 B -3.42% 6393
12/28/2018 €1.04 B -29.64% 5563
12/29/2017 €1.47 B 6.14% 4967
12/30/2016 €1.39 B -9.07% 4984

Company Profile

About Paul Hartmann AG

Paul Hartmann AG is a leading manufacturer and distributor of medical and care products, serving markets across Germany, Europe, the Middle East, Africa, Asia-Pacific, and the Americas. Founded in 1818 and headquartered in Heidenheim, Germany, the company delivers innovative healthcare solutions worldwide.

Business Segments

  • Incontinence Management: Specializes in body-absorbent products.
  • Wound Care: Offers both traditional and modern wound dressings.
  • Infection Management: Provides single-use products and solutions for infection control, disinfection, and skin care.

Product & Service Offerings

  • Hand, surface, and instrument disinfection solutions.
  • Cleaning, skin care, and antisepsis products.
  • Link Platform: A knowledge-sharing hub for medical and clinical expertise.

Distribution Channels

Paul Hartmann AG products are available through:

  • Pharmacies
  • Medical supply stores
  • Online platforms

Frequently Asked Questions

  • What is Paul Hartmann AG's (FRA-PHH2) current market cap?
    As of 06/27/2025, Paul Hartmann AG (including the parent company, if applicable) has an estimated market capitalization of $1.01 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Paul Hartmann AG global market capitalization ranking is approximately 9482 as of 06/27/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.